【原著論文】

1. Kagioka K, Yasuda M, Okune M, Kakehi K, Kawamura T, Kobuke K, Miyazaki S, Iwanaga Y. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging. Clin Res Cardiol. 2020 in press.　
2. Kawamura T, Yasuda M, Okune M, Kakehi K, Kagioka Y, NakamuraT, Miyazaki S, Iwanaga Y. Increased left ventricular trabeculation is associated with increased BNP level and impaired outcomes in non-ischemic cardiomyopathy. Can J Cardiol. 36:518-526, 2020.
3. Watanabe H, Onishi K, Kakehi K, Takase T, Yamaji K, Ueno M, Kobuke K, Miyazaki S, Iwanaga Y. Clinical and angiographic factors predicting fractional flow reserve and explaining the visual-functional mismatch in patients with intermediate coronary artery stenosis. Coron Artery Dis. 31:73-80, 2019.
4. Iwanaga Y, Niizuma S, Washio T, Ashida T, Harasawa S, Miyazaki S, Matsumoto N. Clinical significance of increased cardiac troponin T in patients with chronic hemodialysis and cardiovascular disease: comparison to BNP and ANP increase. Kidney and Blood Pressure Research. 44:1050-1062, 2019.
5. Kakehi K, Iwanaga Y, Watanabe H, Sonobe T, Akiyama T, Shimizu S, Yamamoto H, Miyazaki S. Modulation of sympathetic activity and innervation with chronic ivabradine and β-blocker therapies: analysis of hypertensive rats with heart failure. J Cardiovasc Pharmacol Ther. 24:387-396, 2019.
6. Watanabe H, Iwanaga Y, Miyaji Y, Yamamoto H, Miyazaki S. Renal denervation mitigates cardiac remodeling and renal damage in dahl rats: a comparison with β-receptor blockade. Hypertens Res. 39:217-226, 2016.
7. Nakamura T, Iwanaga Y, Yasuda M, Kawamura T, Miyaji Y, Morooka H, Miyazaki S. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis. Int J Cardiovasc Imag. 32:613-620, 2016.
8. Iwanaga Y, Nakamura T, Miyaji Y, Nohara R, Ishimura T, Miyazaki S, on behalf of the Sitagliptin Registry Kinki Cardiologists' Study (SIRKAS) Investigators. Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up. Cardiovasc Diabetol. 15:54, 2016.

【総説、著書など】

1. 岩永善高、宮崎俊一．「治療薬UP-TO-DATE　2020」松澤佑次ら編．メディカルレビュー社、大阪：pp253-257、2020.
2. Iwanaga Y. Ischemia Testing for Coronary Artery Disease. J Coron Artery Dis. 25:1-6, 2019.
3. 岩永善高、宮崎俊一．ガイドライン　外来診療　2019．泉孝英編．日経メディカル開発、東京： pp87-99、2019.
4. 岩永善高、宮崎俊一．「循環器内科専門医バイブル　虚血性心疾患」小室一成ら編．中山書店、東京：pp207-212、2018.
5. 岩永善高、宮崎俊一．臨床と研究2018年6月号特集「危険な冠動脈疾患」大道學館出版部、福岡： pp9-13、2018.
6. 岩永善高、宮崎俊一．日本臨牀76 巻12 号「急性冠症候群の治療の現況と展望」日本臨牀社、東京： pp2083-2088、2018.
7. 岩永善高．日本臨牀76巻増刊号9「NT-pBNP」日本臨牀社、東京： pp636-641、2018.
8. Niizuma S, Iwanaga Y, Yahata T, Miyazaki S. Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease. Front. Cardiovasc. Med. 4:10, 2017.